NCT06639789

Brief Summary

This clinical study evaluates the effect of acute intake of a new vitamin B12 formulation on anaerobic and cognitive performance variables. One of the limiting factors for the potential beneficial effects of vitamin B12 is its bioavailability. This new formula improves this aspect, so that by improving plasma levels of B12 we will be able to relate whether this situation may be related to improved performance or cognitive tasks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

5 months

First QC Date

September 1, 2024

Last Update Submit

October 11, 2024

Conditions

Keywords

Anaerobic performancePowerMental fatigueVitaminsRecovery

Outcome Measures

Primary Outcomes (1)

  • Wingate test

    This test consists of 5 efforts of 30 seconds at maximum intensity with a recovery of 3 minutes on a bike. In this test the peak and average power of each effort and the total average will be evaluated. In addition, the time to maximum peak power and the fatigue index.

    Throughout study completion, an average of 3 weeks

Secondary Outcomes (3)

  • Mental fatigue test

    Throughout study completion, an average of 3 weeks

  • Biochemical markers

    Throughout study completion, an average of 3 weeks

  • Sleep Quality Questionnaire (Pittsburgh)

    Throughout study completion, an average of 3 weeks

Study Arms (2)

Vitamin B12 (B12)

EXPERIMENTAL

Subjects in this group will intake 1 mg/day of vitamin B12 three days before the tests.

Dietary Supplement: Vitamin B12 (B12)

PLACEBO (PLA)

PLACEBO COMPARATOR

Subjects in this group will intake 200 mg/day of microcrystalline cellulose three days before the tests.

Dietary Supplement: PLACEBO (PLA)

Interventions

Vitamin B12 (B12)DIETARY_SUPPLEMENT

The new formulation of vitamin B12 will be ingested 3 days before and on the day of testing (3 hours before).

Vitamin B12 (B12)
PLACEBO (PLA)DIETARY_SUPPLEMENT

The placebo will be ingested 3 days before and the same day of the tests (3 hours before).

PLACEBO (PLA)

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male cyclists who have competed in both junior and amateur categories.
  • Cycling between 6-15 hours of training per week.
  • BMI between 18-25 kg/m2.

You may not qualify if:

  • Smokers or regular alcohol drinkers.
  • Persons suffering from a metabolic, cardiorespiratory or digestive pathology or anomaly.
  • digestive system.
  • People who have suffered an injury in the last 6 months that limits the performance of the study tests. of the study tests.
  • People taking supplements or medication in the 2 weeks before the start of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Center for High Performance Sport. Catholic University of Murcia

La Ñora, Murcia, 30830, Spain

RECRUITING

MeSH Terms

Conditions

Mental Fatigue

Interventions

Vitamin B 12

Condition Hierarchy (Ancestors)

FatigueSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

CorrinoidsTetrapyrrolesPyrrolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingMacrocyclic CompoundsPolycyclic Compounds

Study Officials

  • Francisco Javier J Martínez Noguera

    Research Center for High Performance Sport. Catholic University of Murcia

    STUDY CHAIR

Central Study Contacts

Francisco Javier FJ Martínez Noguera, PhD

CONTACT

Cristian C Marín Pagán, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: A randomized crossover study will be conducted in which 18 subjects will perform the following conditions: B12) 1 mg/d vitamin B12; PLA) 200 mg/d placebo (microcrystalline cellulose) 3 days before physical and cognitive performance tests.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD (Head of the nutrition area of the Research Center for High Performance Sport)

Study Record Dates

First Submitted

September 1, 2024

First Posted

October 15, 2024

Study Start

July 1, 2024

Primary Completion

November 30, 2024

Study Completion

December 31, 2024

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations